Earn rewards for your opinion on lab products.

Get exclusive insights into life science trends.

Stay up to date on research news.

New sequencing workflow efficiently maps protein-protein interactions
August 4, 2021 -- A new tool called protein-protein interaction sequencing (PROPER-seq) allows researchers to map complex networks of proteins within cells of interest without the need for specialized resources, like antibodies or premade gene libraries. The methodology was published in Molecular Cell on August 3. Read More
PacBio reports growth in Q2, acquires Circulomics
August 4, 2021 -- Pacific Biosciences of California (PacBio) announced that its revenues soared a whopping 79% in the second quarter of 2021, and it has acquired the high-molecular-weight DNA extraction company Circulomics. Read More
Regeneron announces creative innovation 2021 winners
August 3, 2021 -- Regeneron announced the winners of its ninth annual Regeneron Prize for Creative Innovation, a competition designed to recognize creativity and independent scientific thinking among postdoctoral fellows and graduate students focused on biomedical research. This year's winners included Sergey Stavisky, PhD, of Stanford University and Nitsan Goldstein of the University of Pennsylvania. Read More
Sunlight causes DNA damage associated with melanoma
August 2, 2021 -- Unlike other cancers, melanoma results from a chemical reaction that damages DNA and is fueled by sunlight, according to a new study published in Science Advances on July 30. Read More
Abcam to purchase BioVision for $340M
August 2, 2021 -- Custom antibody developer Abcam plans to purchase biotechnology firm BioVision for $340 million. Read More
Scientists visualize viruses in motion using advanced electron microscopy
July 30, 2021 -- Advanced electron microscopy has enabled researchers to visualize how human viruses move in high resolution in a near-native environment. The visualization technique, published in Advanced Materials on July 24, could lead to an improved understanding of the molecular mechanisms of vaccines and therapeutics. Read More
Integral Molecular launches protein engineering platform
July 30, 2021 -- Integral Molecular announced the launch of its proprietary protein engineering platform, GeneCanvas, for the optimization of transgenes and other elements that are essential for gene therapy development. Read More
Machine learning identifies genes important for cancer growth
July 29, 2021 -- Using machine learning, researchers have developed a method that evaluates the contributions of all possible tumor mutations to the development and progression of cancer. The results of the study were published in Nature on July 28. Read More
BioTools Innovator selects 10 accelerator finalists
July 29, 2021 -- BioTools Innovator has selected 10 companies to participate in the organization's inaugural three-month virtual mentorship-focused accelerator program. Read More
Cardiac cell protein may be key to preventing heart failure
July 28, 2021 -- A protein that controls calcium signaling within heart cells could help prevent chronic heart failure, according to the results of a new study published in Nature Communications on July 28. The findings point to the protein as a therapeutic target for drugs that could alleviate heart failure. Read More
Amgen to buy private firm Teneobio for $900M
July 28, 2021 -- Amgen will spend $900 million in cash to acquire the privately held biotechnology company Teneobio, which is developing a new class of biologics known as human heavy-chain antibodies. Read More
Blocking some T cells may unleash full power of immune system against cancer
July 27, 2021 -- Researchers have identified a way to restrict regulatory T-cell activity in tumor cells, which in turn can unleash other immune cells to attack tumors in cancer patients. The research is being published in the August 3 issue of the Proceedings of the National Academy of Sciences. Read More
Cytiva, Pall to invest $1.5B in biomanufacturing over next 2 years
July 27, 2021 -- Cytiva and Pall, both Danaher companies, will make major investments in manufacturing capacity and services at 13 sites around the globe supporting life science customers, totaling $1.5 billion over two years. Read More
Bio-Techne launches multiplex spatial genomics assay
July 27, 2021 -- Bio-Techne has expanded its RNAscope in situ hybridization technology portfolio with the release of the new RNAscope HiPlex V2 assay for formalin-fixed, paraffin-embedded and fixed and frozen samples for up to 12 targets. Read More
Optogenetic gene therapy provides hope for retinitis pigmentosa patients
July 26, 2021 -- Optogenetic therapy bypasses traditional methods of repairing defective photoreceptors in the eye by targeting other retinal cells. Recently, three examples of optogenetic therapeutics under development highlight many of the challenges this type of gene therapy faces for the treatment of a devastating genetic eye disease. Read More
CPhI North America
August 10-12
Philadelphia, Pennsylvania United States
Bioprocessing Summit
August 16-19
Boston, Massachusetts United States
6th Annual CAR-TCR Summit
August 30 - September 2
European Congress of Immunology (ECI) 2021
September 1-4
Belgrade Serbia
Medical Affairs Strategic Summit (MASS)
September 13-15
New Brunswick, New Jersey United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter
Latest Tweets